PHTHALAZIN-1-ONE DERIVATIVES USEFUL AS GRK2 INHIBITORS | Patent Publication Number 20220242850
US 20220242850 A1Publication DateAug 4, 2022
Original Assignee
Current AssigneeJanssen Pharmaceuticals Johnson & Johnson
Inventor/ApplicantsGuozhang Xu
Micheal D. Gaul
Micheal D. Gaul
Empower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.